Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Amortization - Deferred ChargesCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

CNO Financial (CNO) Shares Issued (2016 - 2026)

CNO Financial (CNO) has 18 years of Shares Issued data on record, last reported at $5.6 million in Q1 2026.

  • On a quarterly basis, Shares Issued fell 13.85% to $5.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $10.7 million, a 28.19% decrease, with the full-year FY2025 number at $11.6 million, up 3.57% from a year prior.
  • Shares Issued reached $5.6 million in Q1 2026 per CNO's latest filing, up from $2.0 million in the prior quarter.
  • Over the last five years, Shares Issued for CNO hit a ceiling of $8.1 million in Q1 2023 and a floor of $500000.0 in Q2 2023.
  • A 5-year average of $3.2 million and a median of $2.5 million in 2023 define the central range for Shares Issued.
  • On a YoY basis, Shares Issued climbed as much as 137.93% in 2022 and fell as far as 86.27% in 2022.
  • Tracing CNO's Shares Issued over 5 years: stood at $6.9 million in 2022, then plummeted by 69.57% to $2.1 million in 2023, then skyrocketed by 47.62% to $3.1 million in 2024, then tumbled by 35.48% to $2.0 million in 2025, then soared by 180.0% to $5.6 million in 2026.
  • Business Quant data shows Shares Issued for CNO at $5.6 million in Q1 2026, $2.0 million in Q4 2025, and $2.5 million in Q3 2025.